Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes

Clinical trial NCT00102466 · COMPLETED

Trial details

NCT number: NCT00102466
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2005-01-01
Primary completion: 2009-01-01
Enrollment: 1007

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.